{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T10:17:12Z","timestamp":1787912232399,"version":"build-2784847793"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orthop\u00e4die"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00132-026-04873-2","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:40:00Z","timestamp":1785166800000},"page":"714-718","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sollte die operative Behandlung von prim\u00e4ren malignen Knochentumoren nur in High-Volume-Zentren erfolgen?","Should the surgical treatment of primary malignant bone tumors only take place in high-volume centers?"],"prefix":"10.1007","volume":"55","author":[{"given":"Dimosthenis","family":"Andreou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jendrik","family":"Hardes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Guder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Erik","family":"Podleska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina Myline","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Nottrott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Streitb\u00fcrger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"4873_CR1","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1002\/jso.25052","volume":"117","author":"T Abarca","year":"2018","unstructured":"Abarca\u00a0T, Gao\u00a0Y, Monga\u00a0V et\u00a0al (2018) Improved survival for extremity soft tissue sarcoma treated in high-volume facilities. J\u00a0Surg Oncol 117:1479\u20131486","journal-title":"J Surg Oncol"},{"key":"4873_CR2","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/annonc\/mdq589","volume":"22","author":"D Andreou","year":"2011","unstructured":"Andreou\u00a0D, Bielack\u00a0SS, Carrle\u00a0D et\u00a0al (2011) The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. Ann Oncol 22:1228\u20131235","journal-title":"Ann Oncol"},{"key":"4873_CR3","unstructured":"Biermann JS, Hirbe A, Ahlawat S et\u00a0al. (2025) Bone Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. J\u00a0Natl Compr Canc Netw\u00a023"},{"key":"4873_CR4","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1136\/gutjnl-2013-306074","volume":"63","author":"N Brusselaers","year":"2014","unstructured":"Brusselaers\u00a0N, Mattsson\u00a0F, Lagergren\u00a0J (2014) Hospital and surgeon volume in relation to long-term survival after oesophagectomy: systematic review and meta-analysis. Gut 63:1393\u20131400","journal-title":"Gut"},{"issue":"1","key":"4873_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.70224","volume":"132","author":"C Chidiac","year":"2026","unstructured":"Chidiac\u00a0C, Phan\u00a0P, Mcdermott\u00a0KM et\u00a0al (2026) Exploring hospital volume thresholds for improved sarcoma treatment across different age categories in the United States. Cancer 132(1):e70224","journal-title":"Cancer"},{"key":"4873_CR6","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/jso.25719","volume":"120","author":"J Featherall","year":"2019","unstructured":"Featherall\u00a0J, Curtis\u00a0GL, Lawrenz\u00a0JM et\u00a0al (2019) Time to treatment initiation and survival in adult localized, high-grade soft tissue sarcoma. J\u00a0Surg Oncol 120:1241\u20131251","journal-title":"J Surg Oncol"},{"key":"4873_CR7","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.2106\/JBJS.21.01140","volume":"104","author":"T Fujiwara","year":"2022","unstructured":"Fujiwara\u00a0T, Ogura\u00a0K, Alaqeel\u00a0M et\u00a0al (2022) Geographic Access to High-Volume Care Providers and Survival in Patients with Bone Sarcomas: Nationwide Patterns in the United States. J\u00a0Bone Joint Surg Am 104:1426\u20131437","journal-title":"J Bone Joint Surg Am"},{"key":"4873_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41416-024-02868-4","volume":"132","author":"C Gerrand","year":"2025","unstructured":"Gerrand\u00a0C, Amary\u00a0F, Anwar\u00a0HA et\u00a0al (2025) UK guidelines for the management of bone sarcomas. Br J Cancer 132:32\u201348","journal-title":"Br J Cancer"},{"key":"4873_CR9","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1097\/01.sla.0000250438.04393.a8","volume":"245","author":"JC Gutierrez","year":"2007","unstructured":"Gutierrez\u00a0JC, Perez\u00a0EA, Moffat\u00a0FL et\u00a0al (2007) Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg 245:952\u2013958","journal-title":"Ann Surg"},{"key":"4873_CR10","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.spinee.2020.02.020","volume":"20","author":"AL Lazarides","year":"2020","unstructured":"Lazarides\u00a0AL, Kerr\u00a0DL, Dial\u00a0BL et\u00a0al (2020) Does facility volume influence survival in patients with primary malignant bone tumors of the vertebral column? A comparative cohort study. Spine J 20:1106\u20131113","journal-title":"Spine J"},{"key":"4873_CR11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/CORR.0000000000001034","volume":"478","author":"AT Malik","year":"2020","unstructured":"Malik\u00a0AT, Alexander\u00a0JH, Khan\u00a0SN et\u00a0al (2020) Is Treatment at a High-volume Center Associated with an Improved Survival for Primary Malignant Bone Tumors? Clin Orthop Relat Res 478:631\u2013642","journal-title":"Clin Orthop Relat Res"},{"key":"4873_CR12","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/jso.24710","volume":"116","author":"MJ Maurice","year":"2017","unstructured":"Maurice\u00a0MJ, Yih\u00a0JM, Ammori\u00a0JB et\u00a0al (2017) Predictors of surgical quality for retroperitoneal sarcoma: Volume matters. J\u00a0Surg Oncol 116:766\u2013774","journal-title":"J Surg Oncol"},{"key":"4873_CR13","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.2106\/JBJS.L.00913","volume":"95","author":"K Ogura","year":"2013","unstructured":"Ogura\u00a0K, Yasunaga\u00a0H, Horiguchi\u00a0H et\u00a0al (2013) Impact of hospital volume on postoperative complications and in-hospital mortality after musculoskeletal tumor surgery: analysis of a national administrative database. J\u00a0Bone Joint Surg Am 95:1684\u20131691","journal-title":"J Bone Joint Surg Am"},{"key":"4873_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.6004\/jnccn.2020.7644","volume":"19","author":"KC Stoltzfus","year":"2021","unstructured":"Stoltzfus\u00a0KC, Shen\u00a0B, Tchelebi\u00a0L et\u00a0al (2021) Impact of Facility Surgical Volume on Survival in Patients With Cancer. J\u00a0Natl Compr Canc Netw 19:495\u2013503","journal-title":"J Natl Compr Canc Netw"},{"key":"4873_CR15","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.annonc.2021.08.1995","volume":"32","author":"SJ Strauss","year":"2021","unstructured":"Strauss\u00a0SJ, Frezza\u00a0AM, Abecassis\u00a0N et\u00a0al (2021) Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 32:1520\u20131536","journal-title":"Ann Oncol"},{"key":"4873_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2022.101900","volume":"46","author":"L Toth","year":"2023","unstructured":"Toth\u00a0L, Krieg\u00a0AH, Nowakowski\u00a0AM (2023) How much is a leg worth following radical tumor resection in bone sarcomas? Literature review. Surg Oncol 46:101900","journal-title":"Surg Oncol"},{"key":"4873_CR17","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.ijrobp.2017.12.262","volume":"100","author":"S Venigalla","year":"2018","unstructured":"Venigalla\u00a0S, Nead\u00a0KT, Sebro\u00a0R et\u00a0al (2018) Association Between Treatment at High-Volume Facilities and Improved Overall Survival in Soft Tissue Sarcomas. Int J Radiat Oncol Biol Phys 100:1004\u20131015","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Die Orthop\u00e4die"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00132-026-04873-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00132-026-04873-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00132-026-04873-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:27:55Z","timestamp":1787909275000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00132-026-04873-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4873"],"URL":"https:\/\/doi.org\/10.1007\/s00132-026-04873-2","relation":{},"ISSN":["2731-7145","2731-7153"],"issn-type":[{"value":"2731-7145","type":"print"},{"value":"2731-7153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"3 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.\u00a0Andreou: Beratungst\u00e4tigkeit f\u00fcr Springworks Therapeutics, Referentenhonorar von PharmaMar GmbH. J.\u00a0Hardes und A.\u00a0Streitb\u00fcrger: Institutionelle Forschungsunterst\u00fctzung und Reisekostenerstattung von Implantcast GmbH. N.M.\u00a0Engel: Reisekostenerstattung von Implantcast GmbH. W.\u00a0Guder, L.E.\u00a0Podleska und M.\u00a0Nottrott geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}